David John Watson
David John Watson was appointed in a total of 5 companies and resigned from 5 of these appointments.
Role
Director
Country Of Residence
England, United Kingdom
Nationality
British
Date of Birth
March 1972
Occupations
Vice President, Program Leadership And M • Unreported • Senior Director, Global Clinical Operati
Active
0
Resigned
5
Dissolved
0
Other
0
Total
5
Companies
| Company | Timeline | Status | |
| Convergence Pharmaceuticals Limited Director • Director | 30 Mar 2015←3 Years→12 Apr 2018 | Active | |
Panion Limited Director • Vice President, Program Leadership And M | 11 Feb 2015←4 Years→22 Feb 2019 | Dissolved | |
| Convergence Pharmaceuticals Holdings Limited Director • Unreported | 11 Feb 2015←3 Years→12 Apr 2018 | Active | |
| OLD Convergence Pharmaceuticals Limited Director • Vice President, Program Leadership And M | 11 Feb 2015←3 Years→12 Apr 2018 | Active | |
| Biogen Idec Research Limited Director • Senior Director, Global Clinical Operati | 15 Sep 2011←2 Years 2 Months→19 Nov 2013 | Active | |
Mutual People
- Steven John GreenConvergence Pharmaceuticals Holdings Limited, Biogen Idec Research Limited, OLD Convergence Pharmaceuticals Limited, and 1 more are mutual companies.
- Trevor Anthony MillConvergence Pharmaceuticals Limited, OLD Convergence Pharmaceuticals Limited, Biogen Idec Research Limited, and 1 more are mutual companies.
- Lori Elizabeth MochanConvergence Pharmaceuticals Limited, OLD Convergence Pharmaceuticals Limited, Biogen Idec Research Limited, and 1 more are mutual companies.
- Geronimo MartinezOLD Convergence Pharmaceuticals Limited, Biogen Idec Research Limited, Convergence Pharmaceuticals Limited, and 1 more are mutual companies.
- Amit Singh PurwahaBiogen Idec Research Limited, Convergence Pharmaceuticals Holdings Limited, Convergence Pharmaceuticals Limited, and 1 more are mutual companies.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
